Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Toraymyxin Launch in China?

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Nov 08, 2024 11:10am

116 Views

Post# 36303248

RE:Toraymyxin Launch in China?

That's roughly 3-4 times as many cartridges for use in China as would be needed in the US ... and 3-4 times as many PrismMax machines needed, and 3-4 times as many EAA's needed !

I think CG and Toray must be very excited by the opportunity for blood purification devices to go mainstream globally, especially if (when) it receives the FDA gold seal of approval.

MM

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant